Shukra Pharmaceuticals (BOM:524632) 3-Year Book Growth Rate : 46.70% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Shukra Pharmaceuticals 3-Year Book Growth Rate?

Shukra Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Shukra Pharmaceuticals's average Book Value per Share Growth Rate was 81.00% per year. During the past 3 years, the average Book Value per Share Growth Rate was 46.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Shukra Pharmaceuticals was 198.60% per year. The lowest was -61.30% per year. And the median was 2.00% per year.

Competitive Comparison of Shukra Pharmaceuticals's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shukra Pharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shukra Pharmaceuticals's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shukra Pharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Shukra Pharmaceuticals's 3-Year Book Growth Rate falls into.

Shukra Pharmaceuticals 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Shukra Pharmaceuticals (BOM:524632) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Shukra Pharmaceuticals 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Shukra Pharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shukra Pharmaceuticals (BOM:524632) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shukra Pharmaceuticals Ltd (BOM:524632) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054

Website

https://www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.

Shukra Pharmaceuticals (BOM:524632) Headlines

No Headlines